Cart
sales@molnova.com
Pomalidomide-C7-NH2 hydrochloride
CAS No. 2093387-55-2
Pomalidomide-C7-NH2 hydrochloride( —— )
Catalog No. M28257 CAS No. 2093387-55-2
Pomalidomide-C7-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 43 | In Stock |
|
| 10MG | 70 | In Stock |
|
| 25MG | 149 | In Stock |
|
| 50MG | 231 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePomalidomide-C7-NH2 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomalidomide-C7-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
-
DescriptionPomalidomide-C7-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorphosphodiesterase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2093387-55-2
-
Formula Weight422.91
-
Molecular FormulaC20H27ClN4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.NCCCCCCCNc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Deyama, Takeshi, et al. Inhibition of Adenosine 3', 5'-Cyclic Monophosphate Phosphodiesterase by Lignan Glucosides of Eucommia Bark. From Chemical & Pharmaceutical Bulletin (1988), 36(1), 435-9.
molnova catalog
related products
-
PRX-08066 Maleic aci...
PRX-08066 Maleic acid is a selective 5-HT2B receptor antagonist with IC50 of 3.4 nM, prevents the severity of pulmonary arterial hypertension in the MCT rat model. Phase 2.
-
Recainam
Recainam is a novel, orally available compound with potent class I antiarrhythmic activity.
-
Fluorescamine
Fluorescamine ( Ro 20-7234) is not fluorescent itself but reacts with primary amines to form highly fluorescent products. It is used to detect amines and peptides.
